Comparative Efficacy of Oral Pharmaceuticals for the Treatment of Chronic Peripheral Neuropathic Pain: Meta-Analysis and Indirect Treatment Comparisons

Pain Medicine (United States)

Volumn 14, Issue 5, 2013, Pages 706-719

  Ney, John Peter ^a   Devine, Emily Beth ^a   Watanabe, Jonathan H ^b   Sullivan, Sean D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Chronic Pain; Neuropathy; Pain Management; Polyneuropathy; Randomized Controlled Trial

Indexed keywords

ANALGESIC AGENT; DEXTROMETHORPHAN PLUS QUINIDINE; DULOXETINE; HARKOSERIDE; OPIATE; OXCARBAZEPINE; PARACETAMOL; PLACEBO; PREGABALIN; TOPIRAMATE; ZONISAMIDE;

ANALGESIA; ARTICLE; BREAKTHROUGH PAIN; CHRONIC PAIN; CHRONICITY; COMPARATIVE EFFECTIVENESS; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; HUMAN; INTENTION TO TREAT ANALYSIS; LIKERT SCALE; META ANALYSIS; NEUROPATHIC PAIN; PAIN; PLACEBO EFFECT; POLYNEUROPATHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; STEADY STATE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

EID: 84878194001     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12091     Document Type: Article

References (48)

1. Merskey H, Bogduk N. Classification of Chronic Pain. Seattle, WA: IASP Press; 1994.
2. Treede RD, Jensen TS, Campbell JN, etal. Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630-1635.
3. Bowsher D. Neurogenic pain syndromes and their management. Br Med Bull 1991;47:644-666.
4. Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008;136:380-387.
5. Torrance N, Smith BH, Bennett MI, Lee AJ. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 2006;7:281-289.
6. Merskey H. Introduction. Pain 1986;24:S3-8.
7. O'Connor AB, Dworkin RH. Treatment of neuropathic pain: An overview of recent guidelines. Am J Med 2009;122:S22-32.
8. Dworkin RH, O'Connor AB, Audette J, etal. Recommendations for the pharmacological management of neuropathic pain: An overview and literature update. Mayo Clin Proc 2010;85:S3-14.
9. Cepeda MS, Farrar JT. Economic evaluation of oral treatments for neuropathic pain. J Pain 2006;7:119-128.
10. Moore RA, Moore OA, Derry S, etal. Responder analysis for pain relief and numbers needed to treat in a meta-analysis. Ann Rheum Dis 2010;69:374-379.
11. Hrobjartsson A, Gotzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010;(1):CD003974.
12. Ioannidis JP. Adverse events in randomized trials: Neglected, restricted, distorted, and silenced. Arch Intern Med 2009;169:1737-1739.
13. Jadad AR, Moore RA, Carroll D, etal. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12.
14. Deeks J. Are you sure that's a standard deviation? (Part 2). Cochrane News 1997;11-12.
15. Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Chichester UK: John Wiley & Sons, Ltd; 2009.
16. Petitti D. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine, 2nd edition. New York: Oxford University Press; 2000.
17. Hardy RJ, Thompson SG. Detecting and describing heterogeneity in meta-analysis. Stat Med 1998;17:841-856.
18. Berkey CS, Hoaglin DC, Mosteller F, Colditz GA. A random-effects regression model for meta-analysis. Stat Med 1995;14:395-411.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
20. Peto R. Why do we need systematic overviews of randomized trials? Stat Med 1987;6:233-244.
21. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-1101.
22. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
23. Jansen JP, Crawford B, Bergman G, Stam W. Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health. United States, 2008:956-964.
24. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002;21:2313-2324.
25. Arezzo JC, Rosenstock J, Lamoreaux L, Pauer L. Efficacy and safety of pregabalin 600mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial. BMC Neurol 2008;8:33.
26. Atli A, Dogra S. Zonisamide in the treatment of painful diabetic neuropathy: A randomized, double-blind, placebo-controlled pilot study. Pain Med 2005;6:225-234.
27. Dogra S, Beydoun S, Mazzola J, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: A randomized, placebo-controlled study. Eur J Pain 2005;9:543-554.
28. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005;115:254-263.
29. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005;116:109-118.
30. Raskin P, Donofrio PD, Rosenthal NR, etal. Topiramate vs placebo in painful diabetic neuropathy: Analgesic and metabolic effects. Neurology 2004;63:865-873.
31. Raskin J, Pritchett YL, Wang F, etal. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005;6:346-356.
32. Shaibani A, Fares S, Selam JL, etal. Lacosamide in painful diabetic neuropathy: An 18-week double-blind placebo-controlled trial. J Pain 2009;10:818-828.
33. Thienel U, Neto W, Schwabe SK, Vijapurkar U. Topiramate in painful diabetic polyneuropathy: Findings from three double-blind placebo-controlled trials. Acta Neurol Scand 2004;110:221-231.
34. Tolle T, Freynhagen R, Versavel M, Trostmann U, Young JP, Jr. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double-blind study. Eur J Pain 2008;12:203-213.
35. van Seventer R, Feister HA, Young JP, Jr., etal. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: A 13-week, randomized trial. Curr Med Res Opin 2006;22:375-384.
36. Wernicke JF, Pritchett YL, D'Souza DN, etal. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006;67:1411-1420.
37. Wymer JP, Simpson J, Sen D, Bongardt S. Efficacy and safety of lacosamide in diabetic neuropathic pain: An 18-week double-blind placebo-controlled trial of fixed-dose regimens. Clin J Pain 2009;25:376-385.
38. Ziegler D, Hidvegi T, Gurieva I, etal. Efficacy and safety of lacosamide in painful diabetic neuropathy. Diabetes Care 2010;33:839-841.
39. Beydoun A, Shaibani A, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: Results of a dose-ranging study. Acta Neurol Scand 2006;113:395-404.
40. Shaibani AI, Pope LE, Thisted R, Hepner A. Efficacy and safety of dextromethorphan/quinidine at two dosage levels for. Pain Med 2012;13:243-254.
41. Satoh J, Yagihashi S, Baba M, etal. Efficacy and safety of pregabalin for treating neuropathic pain associated with. Diabet Med 2011;28:109-116.
42. Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst Rev 2009;(4):CD007115.
43. D'Amico D. Pharmacological prophylaxis of chronic migraine: A review of double-blind placebo-controlled trials. Neurol Sci 2010;31(suppl 1):S23-28.
44. Dworkin RH, Turk DC, Wyrwich KW, etal. Interpreting the clinical importance of treatment outcomes in chronic pain. J Pain 2008;9:105-121.
45. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010;150:573-581.
46. Quilici S, Chancellor J, Lothgren M, etal. Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain. BMC Neurol 2009;9:6-19.
47. Backonja M, Wallace MS, Blonsky ER, etal. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: A randomised, double-blind study. Lancet Neurol 2008;7:1106-1112.
48. Yuan RY, Sheu JJ, Yu JM, etal. Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial. Neurology 2009;72:1473-1478.